Faculty

PP211 | Rising to New Heights: Bold Strategies for Revolutionizing Healthcare 

Franklin Owusu, MBA, MPA, FACHE, Administrator, Hospital Operations, The Ohio State University Wexner Medical Center, Columbus, Ohio 

Deepak Rai, MD, Area Medical Director, Medical Units University Hospital, The Ohio State University Wexner Medical Center, Columbus, Ohio 

Alisha Alabre-Bonsu, MD, MA, Cardiovascular Medicine Fellow, Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio 

Brian Bosworth, MD, Chief Medical Officer and Patient Safety Officer, NYU Langone, New York, NY 

Katherine Hochman, MD, MBA, Director, Division of Hospital Medicine, NYU Langone, New York, NY 

Lisa Harton, PhD, MBA, MPH, RN, Chief Quality Officer, Bellin Health, Green Bay, Wis. 

Sharla Baenen, MSN, RN, FABC, Chief Operating Officer, Bellin Health, Green Bay, Wis. 

Shon Dwyer, RN, MBA, Hospital President, Vanderbilt University Medical Center, Nashville, Tenn. 

Warren Sandberg, MD, PhD, Chief of Staff and Department Chair, Vanderbilt University Medical Center, Nashville, Tenn. 

Eric M. Lee, MBA, Senior Director, Strategy & Improvement, Vanderbilt University Medical Center, Nashville, Tenn. 

Lee Ann Liska, MBA, FACHE, Hospital Chief Operating Officer, Vanderbilt University Medical Center, Nashville, Tenn. 

Disclosure

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

FDA Off-Label Use

Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.

Disclosure Statements

Absence of Relevant Financial Relationships

None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure